A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


August 31, 2011

Only 4 ADAPs Provide Guidelines-Recommended Cardio Meds

Only four AIDS Drug Assistance Programs (ADAPs) are providing medications to help manage four major cardiovascular disease (CVD) risk factors common among people living with HIV: type 2 diabetes, high blood pressure, elevated cholesterol and triglyceride levels and smoking. This is the finding of a survey published in the Journal of General Internal Medicine (JGIM) and reported by aidsmap.

While many ADAPs do provide access to many, if not all, of the available antiretrovirals (ARVs) for people living with HIV who qualify for assistance—about one third of HIV-positive people in the United States—coverage for medications needed to prevent or treat health complications related to, or exacerbated by, HIV infection is limited.

According to the JGIM analysis, only four state ADAPs—Massachusetts, New Jersey, New York and Pennsylvania—provided prescription drug coverage consistent with guidelines for all four cardiovascular risk factors. However, 68 percent of states and territories provided therapy that was at least partially consistent with guidance for one risk factor. No coverage was provided by 25 percent of ADAPs.

“In our systematic survey of ADAP formularies, we identified only four states that provided prescription drug coverage consistent with clinical practice guidelines for all four modifiable cardiovascular risk factors,” write the investigators.

According to aidsmap, the study authors believe that financial pressures and cost cutting could lead to some ADAPs restricting their access to non-HIV medications.

The researchers conclude that policymakers should address the “root causes” for the variations in coverage and “provide a comprehensive ADAP formulary informed by clinical guidelines.”

Search: AIDS Drug Assistance Program, ADAP, cardiovascular, CVD, prevention, diabetes, smoking, blood pressure, hypertension, cholesterol, triglycerides

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.